Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EXCO Technologies Ltd. | 3XT | Apr 25, 2025 | 3.52 | +1.15 |
Exedy Corporation | 64M | Apr 25, 2025 | 24.80 | +3.33 |
EXEL COMPOSITES OYJ | 8TY | Apr 25, 2025 | 0.35 | +0.86 |
Exel Industries | 8YK | Apr 25, 2025 | 34.20 | -1.44 |
Exelixis, Inc. | EX9 | Apr 25, 2025 | 32.61 | +3.00 |
Exelon Corporation | PEO | Apr 25, 2025 | 40.70 | -0.51 |
ExlService Holdings, Inc. | LHV | Apr 25, 2025 | 39.46 | -1.42 |
Exmar NV | 1EX | Apr 25, 2025 | 11.32 | -1.74 |
Exor N.V. | EYX | Apr 25, 2025 | 82.75 | +5.21 |
EXOSENS EO -,425 | H8Y | Apr 25, 2025 | 34.75 | +4.20 |
eXp World Holdings, Inc. | 44Y | Apr 25, 2025 | 7.90 | +0.10 |
Expedia Group, Inc. | E3X1 | Apr 25, 2025 | 139.60 | +4.16 |
Expeditors International of Washington, Inc. | EW1 | Apr 25, 2025 | 96.28 | +6.20 |
Experian PLC | J2B | Apr 25, 2025 | 42.20 | +4.98 |
Experian Plc | J2BA | Apr 25, 2025 | 42.00 | +5.00 |
EXPERT SYSTEM S P A AZIONI ORDINARIE SENZA VALORE (NOMINALE | 3K2 | Apr 25, 2025 | 1.25 | -1.73 |
Exploits Discovery Corp | 634 | Apr 25, 2025 | 0.01 | +2 400.00 |
Exponent, Inc. | EP5 | Apr 25, 2025 | 69.12 | +0.35 |
ExpreS2ion Biotech Holding | 5JD0 | Apr 25, 2025 | 1.77 | +2.31 |
Exro Technologies Inc | 1O2 | Apr 25, 2025 | 0.07 | +122.22 |
Exsitec | 1TI | Apr 25, 2025 | 11.00 | +18.53 |
Extendicare Inc | 5XE | Apr 25, 2025 | 8.40 | +1.20 |
Extra Space Storage Inc. | FG8 | Apr 25, 2025 | 123.60 | +0.04 |
Extreme Networks, Inc. | EXM | Apr 25, 2025 | 10.66 | +6.38 |
Exxaro Resources Ltd | LCQ | Apr 25, 2025 | 7.10 | +2.90 |
EXXON MOBIL CDR REG.S | XON | Apr 25, 2025 | 12.40 | +3.87 |
Exxon Mobil Corporation | XONA | Apr 25, 2025 | 95.62 | +0.97 |
EyePoint Pharmaceuticals, Inc. | PV3B | Apr 25, 2025 | 5.71 | +16.85 |
Ezaki Glico Co. Ltd. | 5EJ | Apr 25, 2025 | 28.00 | -0.71 |
EZCORP, Inc. - Class A Non-Voting | EZ2A | Apr 25, 2025 | 14.40 | +3.60 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.